NasdaqCM - Nasdaq Real Time Price USD
CervoMed Inc. (CRVO)
8.78
+0.14
+(1.62%)
At close: May 16 at 4:00:01 PM EDT
8.70
-0.08
(-0.91%)
After hours: May 16 at 7:47:29 PM EDT
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. John J. Alam M.D. | Co-Founder, CEO, President & Director | 807.8k | -- | 1962 |
| Dr. Sylvie L. Gregoire Pharm.D. | Co-Founder & Director | 42.54k | -- | 1961 |
| Mr. William Robert Elder J.D. | CFO, General Counsel & Corporate Secretary | 548.74k | -- | 1983 |
| Dr. Robert J. Cobuzzi Jr., Ph.D. | COO & Director | 710.23k | -- | 1965 |
| Ms. Kelly Blackburn M.H.A. | Executive Vice President of Clinical Development | 404.94k | -- | 1964 |
| Dr. Mark A. De Rosch Ph.D. | Executive VP of Regulatory, Government Affairs & Program Management | -- | -- | 1964 |
| Dr. Claudia Ordonez M.D. | Senior Vice President of Medical Science | -- | -- | 1966 |
CervoMed Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 15
Description
CervoMed Inc., a biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. Its lead drug candidate is neflamapimod, an orally administered small molecule brain penetrant for the treatment of dementia with Lewy bodies (DLB), Alzheimer's diseases, frontotemporal dementia, and ischemic stroke recovery. The company develops EIP200 for central nervous system which is in preclinical trials. The company was founded in 2010 and is headquartered in Boston, Massachusetts.
Corporate Governance
CervoMed Inc.’s ISS Governance QualityScore as of May 1, 2025 is 7. The pillar scores are Audit: 9; Board: 7; Shareholder Rights: 7; Compensation: 7.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
August 7, 2025 at 8:00 PM UTC - August 11, 2025 at 8:00 PM UTC
CervoMed Inc. Earnings Date
Recent Events
Related Tickers
DWTX Dogwood Therapeutics, Inc.
5.32
-3.10%
PRTG Portage Biotech Inc.
7.89
+4.50%
MURA Mural Oncology plc
2.6500
+4.74%
BDTX Black Diamond Therapeutics, Inc.
1.9500
+1.04%
CGTX Cognition Therapeutics, Inc.
0.3252
+3.21%
QURE uniQure N.V.
13.70
+3.40%
CRVS Corvus Pharmaceuticals, Inc.
3.6100
+0.84%
LXEO Lexeo Therapeutics, Inc.
3.2400
+20.00%
ENSC Ensysce Biosciences, Inc.
2.3400
+9.35%
ALMS Alumis Inc.
5.62
+5.05%